G1 Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 2, 2023
July 26 2023 - 9:00AM
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology
company, will host a webcast and conference call to provide a
financial and corporate update for the second quarter 2023 on
Wednesday August 2, 2023, at 8:30 a.m. ET.
Please note that there is a new process to access the call via
telephone. To register and receive a dial in number and unique PIN
to access the live conference call, please follow this link to
register online. While not required, it is recommended that you
join 10 minutes prior to the start of the event. A live and
archived webcast will be available on the Events &
Presentations page of the company’s website:
www.g1therapeutics.com. The webcast will be archived on the same
page for 90 days following the event.
About G1 TherapeuticsG1 Therapeutics, Inc. is a
commercial-stage biopharmaceutical company focused on the
development and commercialization of next generation therapies that
improve the lives of those affected by cancer, including the
Company’s first commercial product, COSELA® (trilaciclib). G1 has a
deep clinical pipeline and is executing a development plan
evaluating COSELA in a variety of solid tumors, including breast,
lung, and bladder cancers. G1 Therapeutics is based in Research
Triangle Park, N.C. For additional information, please visit
www.g1therapeutics.com and follow us on Twitter
@G1Therapeutics.
G1 Therapeutics® and the G1 Therapeutics logo and
COSELA® and the COSELA logo are trademarks of G1
Therapeutics, Inc.
G1 Therapeutics Contacts:
Will RobertsCommunications OfficerVice President, Investor
Relations and Corporate Communications(919) 907-1944
wroberts@g1therapeutics.com
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From Apr 2024 to May 2024
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From May 2023 to May 2024